COVID-19 Vaccine Safety and Immune Response Study
Part of Infections clinical trials.
This early-stage trial tests a new COVID-19 vaccine designed to teach your immune system to fight the virus. It is for people who have just tested positive for COVID-19 and are otherwise healthy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have tested positive for COVID-19 and your symptoms started within the last 7 days.
- Your white blood cell count (a measure of immune health) must be high enough.
- You must not have HIV, hepatitis B, hepatitis C, or active tuberculosis.
- You cannot be pregnant and you must not be allergic to albumin (a protein sometimes used in vaccines).
- You have not taken part in another vaccine trial in the past 60 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how your immune system responds after a COVID-19 vaccine. It uses detailed blood tests to understand what changes happen in your immune cells and may help researchers improve future vaccines.
This trial tests a new COVID-19 vaccine designed to teach your immune system (T-cells) to fight the coronavirus. It is mainly for healthy adults who are not recently infected or vaccinated, to see how safe it is and how your immune system responds.
This study tests an experimental COVID-19 vaccine to see if it is safe and how well it works against current variants. It is for healthy adults who have had a previous COVID-19 vaccine or infection.
This study measures how strongly your immune system responds to COVID-19 vaccines. It includes people with newly diagnosed tuberculosis and a healthier comparison group, aiming to understand vaccine immune effects and safety.
This study tests a new HIV vaccine in healthy, HIV-negative adults to see if it is safe and creates an immune response. The vaccine uses DNA and a protein to try to teach your body to fight HIV.
This trial tests a new two-part HIV vaccine regimen in healthy adults without HIV. The goal is to see if it is safe and produces an immune response that could help prevent HIV.
Hear when a new Treat and Prevent Covid-19 Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.